Seattle-based Geospiza, the maker of software for biologists, said today that it has been awarded a $1.2 million grant from the Small Business Innovation Research program of the National Institutes of Health, along with collaborators at Weill Cornell Medical College and the Mayo Clinic. The grant will support research to help visualize differences in DNA between normal tissue, and samples from tumors, the company said.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
